Altered toxicological endpoints in humans from common quaternary ammonium compound disinfectant exposure.
7-DHC, 7-Dehydrocholesterol
7-DHD, 7-Dehydrodesmosterol
8-DHC, 8-Dehydrocholesterol
ADBAC, alkyldimethylbenzyl ammonium chloride
ANOVA, analysis of variance
BAC, benzalkonium chloride
CRP, C-reactive protein
DDAC, didecyldimethyl ammonium chloride
Environmental toxicology
FCCP, trifluoromethoxy carbonylcyanide phenylhydrazone
IL-10, interleukin 10
IL-12, interleukin 12
IL-6, interleukin 6
IRB, Institutional Review Board
Inflammation
LC, liquid chromatography
LOD, level of detection
LOQ, level of quantification
LPS, lipopolysaccharide
Lipid metabolism
Mitochondrial function
NF-κB, nuclear factor kappa beta
NOEL, no effect level
OCR, oxygen consumption rate
OEL, occupational exposure limit
QAC, quaternary ammonium compounds
Quaternary ammonium compounds
TNFα, tumor necrosis factor alpha
Journal
Toxicology reports
ISSN: 2214-7500
Titre abrégé: Toxicol Rep
Pays: Ireland
ID NLM: 101630272
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
11
2020
revised:
04
02
2021
accepted:
06
03
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
Humans are frequently exposed to Quaternary Ammonium Compounds (QACs). QACs are ubiquitously used in medical settings, restaurants, and homes as cleaners and disinfectants. Despite their prevalence, nothing is known about the health effects associated with chronic low-level exposure. Chronic QAC toxicity, only recently identified in mice, resulted in developmental, reproductive, and immune dysfunction. Cell based studies indicate increased inflammation, decreased mitochondrial function, and disruption of cholesterol synthesis. If these findings translate to human toxicity, multiple physiological processes could be affected. This study tested whether QAC concentrations could be detected in the blood of 43 human volunteers, and whether QAC concentrations influenced markers of inflammation, mitochondrial function, and cholesterol synthesis. QAC concentrations were detected in 80 % of study participants. Blood QACs were associated with increase in inflammatory cytokines, decreased mitochondrial function, and disruption of cholesterol homeostasis in a dose dependent manner. This is the first study to measure QACs in human blood, and also the first to demonstrate statistically significant relationships between blood QAC and meaningful health related biomarkers. Additionally, the results are timely in light of the increased QAC disinfectant exposure occurring due to the SARS-CoV-2 pandemic. This study found that 80 % of study participants contained QACs in their blood; and that markers of inflammation, mitochondrial function, and sterol homeostasis varied with blood QAC concentration.
Identifiants
pubmed: 33868951
doi: 10.1016/j.toxrep.2021.03.006
pii: S2214-7500(21)00047-0
pmc: PMC8041661
doi:
Types de publication
Journal Article
Langues
eng
Pagination
646-656Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES023513
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003015
Pays : United States
Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Aquat Toxicol. 2003 Mar 17;63(1):43-63
pubmed: 12615420
Toxicol Sci. 2016 Jun;151(2):261-70
pubmed: 26919959
Toxicol Sci. 2019 Jun 14;:
pubmed: 31199489
Toxicol Ind Health. 2020 Sep;36(9):619-633
pubmed: 33241765
Hepatology. 1998 Apr;27(4):1056-63
pubmed: 9537446
Toxicol Lett. 2002 Aug 5;134(1-3):177-84
pubmed: 12191876
J Chromatogr A. 1997 Jul 11;774(1-2):281-6
pubmed: 9253191
Neuropharmacology. 1993 Apr;32(4):377-85
pubmed: 7684515
Toxicol Lett. 2004 Mar 14;148(1-2):113-23
pubmed: 15019095
Presse Med. 1991 Apr 27;20(16):741-3
pubmed: 1828591
Regul Toxicol Pharmacol. 2020 Oct;116:104717
pubmed: 32640297
Sci Total Environ. 2016 Aug 1;560-561:197-203
pubmed: 27101455
J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):257-9
pubmed: 8064078
Toxicol Sci. 2001 Aug;62(2):330-8
pubmed: 11452146
Environ Health Perspect. 2017 Aug 22;125(8):087015
pubmed: 28885978
Chem Res Toxicol. 2019 Dec 16;32(12):2466-2478
pubmed: 31730751
Biochem J. 1973 Dec;136(4):967-78
pubmed: 4786541
Food Chem Toxicol. 1991 Dec;29(12):851-4
pubmed: 1765331
J Anal Toxicol. 2002 Oct;26(7):382-92
pubmed: 12422990
Front Immunol. 2020 Oct 21;11:575179
pubmed: 33193366
Reprod Toxicol. 2016 Jan;59:159-66
pubmed: 26582257
Environ Pollut. 2005 Dec;138(3):379-411
pubmed: 16098930
Reprod Toxicol. 2011 Jan;31(1):59-65
pubmed: 20850520
Curr Protoc Toxicol. 2018 Nov;78(1):e65
pubmed: 30320450
Birth Defects Res. 2017 Aug 15;109(14):1166-1178
pubmed: 28618200
Ecotoxicol Environ Saf. 1985 Jun;9(3):321-6
pubmed: 4006831
Curr Opin Biotechnol. 2015 Jun;33:296-304
pubmed: 25864173
Groundw Sustain Dev. 2019 Apr;8:104-121
pubmed: 30555889
Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):447-53
pubmed: 19697451
Reprod Toxicol. 2014 Dec;50:163-70
pubmed: 25483128
Contact Dermatitis. 2008 May;58(5):285-90
pubmed: 18416759
Environ Pollut. 2012 May;164:150-7
pubmed: 22361053
Pharmacol Ther. 2013 Apr;138(1):142-54
pubmed: 23353097
Sci Total Environ. 2015 Jun 15;518-519:352-62
pubmed: 25770948
J Biol Chem. 1990 Aug 25;265(24):14176-86
pubmed: 2117607
Environ Toxicol. 2011 Apr;26(2):118-23
pubmed: 19768748